Euthymics Bioscience, Inc.
Records under this name other than patents Euthymics Bioscience, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Euthymics Bioscience, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,527,813 | Process for the Synthesis of (+) and (-)-1-(3,4-Dichlorophenyl)-3-Azabicyclo[3.1.0]HEXANE now held by Ethismos Research, Inc. In force · High confidence | In force | High confidence | |
| US 9,205,074 | Novel 1-Aryl-3-Azabicyclo[3.1.0]Hexanes: Preparation And Use To Treat Neuropsychiatric Disorders Term ended Term ended Jul 25, 2026 · Medium confidence | Term ended | Term ended Jul 25, 2026 | Medium confidence |
| US 9,737,506 | Novel 1-Aryl-3-Azabicyclo[3.1.0]Hexanes: Preparation And Use To Treat Neuropsychiatric Disorders Term ended Term ended Jul 25, 2026 · High confidence | Term ended | Term ended Jul 25, 2026 | High confidence |
| US 10,039,746 | Novel 1-Aryl-3-Azabicyclo[3.1.0]Hexanes: Preparation And Use To Treat Neuropsychiatric Disorders Term ended Term ended Jul 25, 2026 · Medium confidence | Term ended | Term ended Jul 25, 2026 | Medium confidence |
| US 8,765,801 | Novel Polymorphs Of Azabicyclohexane now held by Ethismos Research, Inc. Term ended Term ended Aug 16, 2025 · Medium confidence | Term ended | Term ended Aug 16, 2025 | Medium confidence |
| US 9,770,436 | Novel Polymorphs of Azabicyclohexane now held by Ethismos Research, Inc. Term ended Term ended Aug 16, 2025 · Medium confidence | Term ended | Term ended Aug 16, 2025 | Medium confidence |
| US 9,597,315 | Novel 1-Heteroaryl-3-Azabicyclo[3.1.0]HEXANES, Methods for Their Preparation and Their Use as Medicaments now held by Ethismos Research, Inc. Lapsed on the fee record Ended Mar 21, 2021 · Medium confidence | Lapsed on the fee record | Ended Mar 21, 2021 | Medium confidence |
| US 9,566,264 | Novel Combinations and Methods now held by Ethismos Research, Inc. Lapsed on the fee record Ended Feb 14, 2021 · High confidence | Lapsed on the fee record | Ended Feb 14, 2021 | High confidence |
| US 6,372,919 | (+)-1-(3,4-Dichlorophenyl)-3-Azabicyclo[3.1.0]HEXANE, Compositions Thereof, and Uses as an Anti-Depressant Agent now held by Ethismos Research, Inc. Term ended Term ended Jan 11, 2021 · High confidence | Term ended | Term ended Jan 11, 2021 | High confidence |
| US 9,393,204 | Methods and Compositions Employing Bicifadine for Treating Disability or Functional Impairment Associated with Acute Pain, Chronic Pain, or Neuropathic Disorders Lapsed on the fee record Ended Jul 19, 2020 · Medium confidence | Lapsed on the fee record | Ended Jul 19, 2020 | Medium confidence |